• Business case: Investing in Production of High-Quality Misoprostol for Low-Resource Settings 26-03-2015

Business case production of misoprostol

This report by the Reproductive Health Supplies Coalition provides the business case for investing in high-quality misoprostol in low-resource settings. The misoprostol business case is one of a three-part series focused on maternal health products that also includes business cases on the markets for magnesium sulfate and oxytocin. Together, these three maternal health drugs are very effective at preventing maternal deaths, but there are problems with ensuring a reliable supply of high-quality, affordable products for countries
to procure.